In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Qiagen N.V. is one of them. Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation, continues to expand its precision medicine footprint through innovative testing solutions for infectious diseases, cancer genomic profiling, and cell and gene therapy quality control. In Q2 2025, the business reported 7% net sales growth year-over-year, driven by strong adoption of key prod ...